Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer

Breast cancer patients treated with tamoxifen may experience recurrence due to endocrine resistance, which highlights the need for additional predictive and prognostic biomarkers. The glyco-phosphoprotein osteopontin (OPN), encoded by the SPP1 gene, has previously shown to be associated with poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Göthlin Eremo, Anna, Lagergren, Kajsa, Othman, Lana, Montgomery, Scott, Andersson, Göran, Tina, Elisabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989629/
https://www.ncbi.nlm.nih.gov/pubmed/31996744
http://dx.doi.org/10.1038/s41598-020-58323-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989629/
https://www.ncbi.nlm.nih.gov/pubmed/31996744
http://dx.doi.org/10.1038/s41598-020-58323-w

Ejemplares similares